Background. Use of intraoperative somatosensory evoked potential (SSEP) monitoring is helpful in spinal corrective surgery but may be affected by anaesthetic drugs. An anaesthetic technique that has less effect on SSEP or allows faster recovery is an advantage. We compared the effects on SSEP and the clinical recovery pro®les of sevo¯urane/nitrous oxide and propofol anaesthesia during surgery to correct scoliosis.
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The use of continuous or intermittent intraoperative electrophysiological spinal cord monitoring provides information concerning the neurological structures at risk during spinal corrective surgery. The Scoliosis Research Society has published a position statement concerning the use of intraoperative monitoring during spinal surgery, and made recommendations concerning standard monitoring techniques. 1 Somatosensory evoked potentials (SSEP) remain the most widely used monitoring method for spinal surgery.
2 This is largely related to familiarity with the method, comparative ease of application and its proven sensitivity to an array of surgical variables. SSEPs are signal-averaged data, elicited by stimulating a peripheral nerve and recording the response at points along the afferent pathway and across the somatosensory cortex. They are small-amplitude responses that are not identi®able with a single stimulus. Instrumentation used to record these data ampli®es and ®lters the signal over multiple trials to produce a response that can be measured and duplicated. Typically, 300±500 samples are averaged to create one SSEP response and take about 60 s to obtain. They are, therefore, a measure of neural transmission in afferent spinal cord pathways. However, anaesthetic drugs can affect SSEP ®ndings. Sevo¯urane can increase the latency and decrease the amplitude of SSEP in a dose-dependent fashion.
3 Propofol±sufentanil total i.v. anaesthesia has also been shown to in¯uence SSEP monitoring. 4 Anaesthesia may, therefore, affect the interpretation of an unfavourable intraoperative SSEP and a drug that has less effect on SSEP or allows a faster recovery of SSEP after readjustment of anaesthetic dose is advantageous.
Although electrophysiological monitoring is an important breakthrough, the Stagnara`wake-up' test has largely remained the gold standard for assessment of neurological status during spinal surgery. 5 The wake-up test may be required in circumstances in which SSEP signals are undetectable or abnormal. However, timely completion of an intraoperative wake-up test can be dif®cult and the critical time window for reversal of a de®cit can be lost while waiting for a patient to recover consciousness. Should a wake-up test become necessary, an anaesthetic technique that facilitates more rapid, lucid recovery can be helpful. The low blood±gas partition coef®cient of sevo¯urane or the short, context-sensitive half-time of propofol may confer advantages in such scenarios. Previous studies have shown that recovery after sevo¯urane is faster than after isourane, 6 halothane 7 and propofol.
8±11
The aims of this study were (i) to compare inhalational sevo¯urane/nitrous oxide anaesthesia with total i.v. anaesthesia (TIVA) with propofol for their abilities to preserve SSEP monitoring signals during corrective scoliosis surgery, and (ii) to compare the wake up pro®les of these techniques.
Patients and methods
Approval for this prospective, randomized study was obtained from the research ethics committee of the University of Hong Kong. Twenty patients with adolescent idiopathic scoliosis undergoing spinal fusion and instrumentation at the Duchess of Kent Children's Hospital were enrolled. All patients were ASA class II. Patients with neurological de®cit, congenital musculoskeletal disease, learning dif®culties or cerebral palsy were excluded. Informed consent was obtained from all patients and their parents.
Patients were allocated randomly into two groups of 10. Randomization was done by drawing lots from an envelope containing 20 small pieces of paper, 10 marked`S' and 10 marked`P'. Group 1 (lots marked S) received sevo¯urane/ nitrous oxide inhalational anaesthesia and Group 2 (lots marked P) received propofol TIVA. EMLA cream (AstraZeneca LP, Wilmington, USA) was applied to facilitate painless insertion of an i.v. cannula and patients were not premedicated. Anaesthesia was induced with alfentanil 40 mg kg ±1 and propofol 2±3 mg kg ±1 . Atracurium 0.5 mg kg ±1 was given for muscle relaxation and was followed by tracheal intubation and intermittent positive pressure ventilation. Maintenance of anaesthesia in the sevo¯urane group was provided with a mixture of 65% nitrous oxide and 35% oxygen with 0±3% sevo¯urane [<1.5 minimum alveolar concentration (MAC)], titrated to clinical requirement. Anaesthesia was maintained in Group 2 by target-controlled infusion (TCI) of propofol (Diprifusor; AstraZeneca) at a plasma concentration of 2±5 mg ml ±1 , titrated to clinical requirement while the patient was ventilated with 35% oxygen in air. Muscle relaxation was maintained with atracurium 0.3±0.5 mg kg ±1 h ±1 . Intraoperative analgesia was provided by an alfentanil infusion of 0.4±1.0 mg kg ±1 min ±1 , with intermittent boluses of 150±500 mg as required. No other opioid was given until after completion of the study. The infusion of atracurium was discontinued towards the end of surgery and reversed using neostigmine 40 mg kg ±1 and atropine 20 mg kg ±1 . Patients were kept normothermic with forced air warmers.
Intraoperative monitoring included intraradial invasive arterial blood pressure, rectal temperature, capnography, end-tidal sevo¯urane concentration, pulse oximetry, central venous pressure, urine output and peripheral nerve stimulation. Arterial blood gases and haematocrit were checked intermittently. SSEP signals were collected over Cz¢ (2 cm posterior to Cz; 10±20 international system of EEG electrode placement) and Cv (over the cervical spinal process of C2) vs the Fz of the 10±20 system ( Fig. 1) . 12 To elicit SSEPs, a pair of stimulating electrodes was applied over the posterior tibial nerve behind the medial malleolus. The stimulation current used ranged from 10 to 30 mA and was kept constant once selected for a particular patient. The normal current density was adjusted to produce a small movement of the toes. Single-pulse stimulation with a frequency between 5.1 and 5.7 Hz and duration of 200 ms was applied. An intraoperative spinal cord monitoring system (Viking IV; Nicolet Biomedical, Madison, WI, USA) was employed to record the responses with a 20±3000 Hz bandpass ®lter. Continuous 100 times averaging was used. The initial negative and positive waves were identi®ed in the SSEP tracings so that the latency and the peak-to-peak amplitude could be measured. The intensity changes related to anaesthesia were also noted during surgery. The mean values and standard deviations of these variables were calculated for each patient. The withinpatient variability was calculated from the ratio of the standard deviation to the mean [(SD/mean)Q100%].
The results for the two groups were analysed statistically with the paired Student's t-test, with the level of signi®cance set at P<0.05. Statistical analysis was performed using SPSS 8.0 for PC Windows (SPSS, Chicago, IL, USA). The changes in SSEP amplitude in response to changes in anaesthetic dose were analysed with a scatter chart corresponding to time, where the trend lines of SSEP amplitude and anaesthetic dose changes were plotted with a best-®t polynomial function. The delay period was measured between the in¯ection points of the trend line of anaesthetic dose and SSEP variables. The delay periods were de®ned as two types of change in anaesthetic dose. One was the doseincrease period, i.e. decrease in SSEP amplitude with increasing anaesthetic dose. The dose-increase period was measured from the time the dose was increased by 30% from the baseline to the time that the SSEP amplitude reached a plateau. The other was the`dose-decrease' period, measured from the time that the dose was decreased back to baseline to the time that the SSEP amplitude increased to 70% of its baseline value. Figure 2 illustrates an example of the measurement of the dose-increase and dose-decrease periods in a patient undergoing sevo¯urane anaesthesia; the dose changes are represented by MAC. If the patient received propofol anaesthesia, similar measurements were made on the plot of the trend line for dose change, the measurement unit being mg ml ±1 . Anaesthetic agents were stopped when the patient had been turned to the supine position after completion of surgery. Recovery was assessed with a simulated wake-up test. The patients were asked to open their eyes and move their toes and the time interval from cessation of anaesthesia was recorded. A behavioural score was determined at this point. As the physicians could not be blinded to the anaesthesia technique, it was necessary to provide a simple classi®cation of the level of consciousness in order to decrease observer bias: 1=calm/cooperative/good; 2=con-fused/restless/disorientated; 3=drowsy/unable to obey commands.
Results
There were 10 patients in each group. All patients were female and Chinese. There was no signi®cant difference between the groups with respect to age and weight. Table 1 shows the within-patient variability of SSEP variables related to the changes of doses of the different anaesthetic agents. Changing the anaesthetic dose produced little effect Units are MAC in the sevo¯urane group and mg ml ±1 in the propofol group. The lower curve shows contemporaneous changes in SSEP amplitude (mV). The dose-increase period was measured from the point when the dose was increased by 30% from the baseline to the time when the SSEP amplitude reached a plateau. The dose-decrease period was measured from the point when the dose returned to baseline to the point when SSEP amplitude had increased to 70% of its baseline value.
on the latency of SSEP. The effect on the variability of Cz¢ SSEP amplitude was statistically signi®cant (P<0.05) compared with Cv SSEP amplitude, suggesting that Cv SSEP is more resistant to the effects of anaesthesia. There was no difference between the two anaesthetic techniques in this regard.
The dose-increase and dose-decrease delay periods were both shorter in the sevo¯urane group (P<0.05, Table 2 ), indicating a faster decrease in SSEP and faster recovery than for propofol. The recovery times are also shown in Table 2 . There was no correlation between duration of anaesthesia or total dose of alfentanil and time to toe movement or eye opening (Table 3) . A contingency table was constructed to compare the behavioural scores on emergence between the two groups (Table 4) . Patients in the sevo¯urane group were signi®cantly more lucid and cooperative.
Discussion
Spinal cord monitoring with SSEP has become a routine technique for detecting cord injury during spinal surgery, allowing early intervention to avoid permanent impairment. Its use has been found to correlate with neurosurgical outcome [13±15] . The effects of anaesthetic drugs on SSEP are, therefore, an important consideration. Our study shows that propofol and sevo¯urane/nitrous oxide affect the amplitude of SSEP to a similar extent, assuming that the depth of anaesthesia is comparable in the two groups. Such a comparison, however, is dif®cult as it is not possible to measure the actual plasma concentration of propofol in real time (unlike end-tidal sevo¯urane concentration) and, therefore, to make a direct comparison between sevo¯urane MAC and the median effective concentration of propofol (EC 50 ). The bias and accuracy of the TCI system used has, however, been shown to be satisfactory, 16 17 and clinical signs of anaesthetic depth were the same in both groups. Processed EEG modalities, such as the bispectral index (BIS) and the middle latency auditory evoked response (AEP), can be helpful in monitoring anaesthetic depth but neither has the sensitivity nor speci®city to allow the clinician to draw conclusions about the depth of anaesthesia in individual patients. Furthermore, the values seen at similar clinical levels of anaesthesia vary according to the anaesthetic drug used. 18 However, the possibility that sevo¯urane has a lesser effect on SSEP because of differences in the depth of anaesthesia cannot be discounted.
A sevo¯urane concentration up to 1.0 MAC was still compatible with SSEP recording. 3 Other studies have found that propofol/alfentanil TIVA provides a better signal-tonoise ratio than en¯urane or iso¯urane anaesthesia, thereby allowing more frequent and reliable intraoperative SSEP recordings. 19 The TCI plasma propofol concentration that can preserve SSEP signals adequately is still to be determined. Our results also show that there is a signi®cant change in SSEP Cz¢ amplitude in response to changes in anaesthetic concentration when compared with SSEP Cv amplitude. This may re¯ect the cerebral effect of anaesthetic drugs rather than their effect on the spinal cord.
Sometimes a higher concentration of anaesthetic may be required during surgical manipulation and a drug that allows faster recovery of SSEP after readjustment therefore permits more accurate interpretation of the data. In this regard, we found that sevo¯urane had signi®cantly shorter doseincrease and dose-decrease periods than propofol. Also, the smaller standard deviation suggests that the recovery time required is more predictable than that with propofol. In interpreting SSEP, however, it is important to realize that false negative results may occur because monitoring is pathway-speci®c and an injury not involving the pathway may not be detected. Failure to monitor both latency and 22 Changes in SSEP may also be produced by physiological factors such as severe hypotension, hypoxia, hyperthermia and a large decrease in haematocrit (to less than 15%). 23 These did not occur in any of the patients in our study.
As well as a faster recovery time, our data from the behavioural scores showed that sevo¯urane produces a better conscious state on emergence. As both groups were homogeneous with respect to age, sex, body weight, ethnicity and surgery, we can assume that this is related to the anaesthetic technique. Although there was some variation in the duration of anaesthesia and individual consumption of alfentanil, there was no correlation between the duration of anaesthesia or total dose of alfentanil per unit body weight and the recovery indices, i.e. times from cessation of anaesthesia to toe movement and eye opening. This is interesting, considering recent reports of restlessness in paediatric patients recovering from sevo¯urane anaesthesia. 24 25 A calm and cooperative patient is obviously preferable after spine stabilization surgery and in the event of a wake-up test being required.
Sevo¯urane has been associated with more nausea and vomiting than propofol. 11 In our study, two patients in the sevo¯urane group developed postoperative nausea and vomiting, but none in the propofol group did so before commencement of patient-controlled anaesthesia with morphine. Although propofol appears to have intrinsic antiemetic properties, the number of patients in this study was too small to demonstrate this. One patient receiving sevo¯urane had involuntary movement on wakening, but this was transient with no clinical consequence.
In conclusion, this study showed that both sevo¯urane and propofol produced a signi®cant change in SSEP amplitude but sevo¯urane produced this change more quickly and with faster recovery than propofol. Patients receiving sevo¯urane also had a faster, more predictable recovery from anaesthesia and a calmer, more cooperative state on emergence.
